Tenecteplase vs Alteplase in Stroke & Pulmonary Embolism is organized by Central Michigan University (CMU) College of Medicine.
Event Date: February 13, 2024
End Date: February 13, 2027
Description:
This topic will highlight evidence for use of thrombolytics in patients with acute ischemic stroke and pulmonary embolism. This course will compare the pharmacology, efficacy, safety and formulary considerations of thrombolytic alteplase and tenecteplase.
Learning Objectives:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Central Michigan University College of Medicine and Covenant Hospital Critical Care. CMU College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Central Michigan University College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Michigan Board of Nursing, American Nurses Credentialing Center (ANCC), American Academy of Nurse Practitioners (AANP) and the National Commission on Certification of Physician Assistants (NCCPA) accept AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved